LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
BCIQ Data Coverage
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
3rd Biotech CEO & Investor Reception
East-West Biopharma Summit 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Abionyx Pharma S.A.
Headquarters:
Balma, Cedex, France
Website:
https://www.abionyx.com/en/
Year Founded:
2005
Status:
Public
Industry Sector:
HealthTechnology
CEO:
Cyrille Tupin, CPA
Number Of Employees:
51
Enterprise Value:
$41,276,308
PE Ratio:
-30.66
Exchange/Ticker 1:
Euronext Paris:ABNX
Exchange/Ticker 2:
N/A
Latest Market Cap:
$162,287,833
BioCentury
|
Jul 30, 2024
Product Development
Venturing beyond AAVs and LNPs to deliver therapeutic cargo
Dozens of companies aim to avoid immunogenicity and improve tissue-specificity
Read More
BioCentury
|
Jan 15, 2022
Finance
4Q21 Wrap: the bleeding continues
Biopharmas continued to slump in 4Q21 across all market cap tiers
Read More
BioCentury
|
Dec 3, 2021
Distillery Therapeutics
An APOA1 mimic peptide for silica-induced cardiovascular damage
Read More
BioCentury
|
Apr 7, 2017
Finance
Fade to black
Biotech winners, losers in 1Q17
Read More
Items per page:
10
1 - 4 of 4